Salvatore Badalamenti

Salvatore Badalamenti

Auto-generated profile, based on publicly available information

Salvatore Badalamenti

IRCCS Humanitas Clinical Research Hospital, via Manzoni 56, Rozzano, 20089 Milan, Italy

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2003 in American Journal of Kidney Diseases
Verified
Journal Article
Closed access
SBSalvatore Badalamenti
Salvatore Badalamenti
ACAnna Catania
Anna Catania
GLGiovanna Lunghi
Giovanna Lunghi
GCGiovanni Covini
Giovanni Covini
EBElena Bredi
Elena Bredi
GGGiorgio Graziani
Giorgio Graziani

31 January 1997 in Kidney International
Verified
Journal Article
Closed access
MSMaurizio Sampietro
Maurizio Sampietro
SBSalvatore Badalamenti
Salvatore Badalamenti
GGGiorgio Graziani
Giorgio Graziani
GCGiovanna Como
Giovanna Como
GBGherardo Buccianti
Gherardo Buccianti
CPClaudio Ponticelli
Claudio Ponticelli

Verified
Journal Article
Open access
PDF file
Garavaglia Maria LisaGaravaglia Maria Lisa
Garavaglia Maria Lisa
Daniela GiustariniDaniela Giustarini
Daniela Giustarini
GCGraziano Colombo
Graziano Colombo
FRFrancesco Reggiani
Francesco Reggiani
SFSilvia Finazzi
Silvia Finazzi
IDIsabella Dalle-Donne
Isabella Dalle-Donne
Thiols (sulfhydryl groups) are effective antioxidants that can preserve the correct structure of proteins, and can protect cells and tissues from damage induced by oxidative stress. Abnormal levels of thiols have been measured in the blood of patients with moderate-to-severe chronic kidney disease (CKD) compared to healthy subjects, as well as in end-stage renal disease (ESRD) patients on haemodialysis or peritoneal dialysis. The levels of protein thiols (a measure of the endogenous antioxidant capacity inversely related to protein oxidation) and S-thiolated proteins (mixed disulphides of protein thiols and low molecular mass thiols), and the protein thiolation index (the molar ratio of the S-thiolated proteins to free protein thiols in plasma) have been investigated in the plasma or red blood cells of CKD and ESRD patients as possible biomarkers of oxidative stress. This type of minimally invasive analysis provides valuable information on the redox status of the less-easily accessible tissues and organs, and of the whole organism. This review provides an overview of reversible modifications in protein thiols in the setting of CKD and renal replacement therapy. The evidence suggests that protein thiols, S-thiolated proteins, and the protein thiolation index are promising biomarkers of reversible oxidative stress that could be included in the routine monitoring of CKD and ESRD patients.


25 April 2021 in Cancers
Verified
Journal Article
Open access
PDF file
Ana LleoAna Lleo
Ana Lleo
FCFrancesca Colapietro
Francesca Colapietro
PMPatrick Maisonneuve
Patrick Maisonneuve
MAMonia Aloise
Monia Aloise
VCVincenzo Craviotto
Vincenzo Craviotto
AAAlessio Aghemo
Alessio Aghemo
Cholangiocarcinomas (CCAs) are a heterogeneous group of tumors that arise from the biliary tract. Jaundice is a common clinical presentation; however, the prognostic impact of this symptom is poorly understood, and current management recommendations lack solid evidence. We aim to assess the clinical outcomes and predictive factors of CCA patients presenting with jaundice in the Emergency Room (ER). We retrospectively analyzed all consecutive ER cases presenting with jaundice between January 2010 and December 2017. During the study period, 403,766 patients were admitted to the ER, 1217 (0.3%) presented with jaundice, and in 200 (0.049%), the diagnosis was CCA. CCA cases increased during the study period (p for trend 0.026). Most of them presented with advance disease (stage III 46.5%, stage IV 43.5%) and median survival was 4.5 months (95% CI 3.4–6.0). Factors associated with better survival were age, stage of disease, presence of jaundice at the moment of diagnosis, and lack of concomitant viral hepatitis. A nomogram was constructed that significantly predicts 1-month, 6-month, and 1-year survival after patients’ admission. In conclusion, the majority of CCA patients presenting with jaundice to the ER have advanced disease and poor prognosis. Risk stratification of these patients can allow tailored management.

8 October 2021 in Applied Sciences
Verified
Journal Article
Open access
PDF file
Antonio VozaAntonio Voza
Antonio Voza
ADAntonio Desai
Antonio Desai
Sabino LuzziSabino Luzzi
Sabino Luzzi
ALAlice Giotta Lucifero
Alice Giotta Lucifero
EAElena Azzolini
Elena Azzolini
MCMaurizio Cecconi
Maurizio Cecconi
The region of Lombardy was the epicenter of the COVID-19 outbreak in Italy. Emergency Hospital 19 (EH19) was built in the Milan metropolitan area during the pandemic’s second wave as a facility of Humanitas Clinical and Research Center (HCRC). The present study aimed to assess whether the implementation of EH19 was effective in improving the quality of care of COVID-19 patients during the second wave compared with the first one. The demographics, mortality rate, and in-hospital length of stay (LOS) of two groups of patients were compared: the study group involved patients admitted at HCRC and managed in EH19 during the second pandemic wave, while the control group included patients managed exclusively at HCRC throughout the first wave. The study and control group included 903 (56.7%) and 690 (43.3%) patients, respectively. The study group was six years older on average and had more pre-existing comorbidities. EH19 was associated with a decrease in the intensive care unit admission rate (16.9% vs. 8.75%, p < 0.001), and an equal decrease in invasive oxygen therapy (3.8% vs. 0.23%, p < 0.001). Crude mortality was similar but overlap propensity score weighting revealed a trend toward a potential small decrease. The adjusted difference in LOS was not significant. The implementation of an additional COVID-19 hospital facility was effective in improving the overall quality of care of COVID-19 patients during the first wave of the pandemic when compared with the second. Further studies are necessary to validate the suggested approach.